Empowering Lives in the CommunitiesWe Serve
Communications Fellowship Program
The Cytokinetics Communications Fellowship Grant program provides $100,000 in grants to five selected patient advocacy organizations serving the amyotrophic lateral sclerosis (ALS), heart failure, hypertrophic cardiomyopathy (HCM), or spinal muscular atrophy (SMA) communities. It is awarded annually to provide funding in support of communications, awareness and outreach. The goal of the Fellowship is to assist patient advocacy organizations by increasing resources in order to better support patient communities and bring increased awareness to the disease in the communities they serve. The Fellowship may support additional personnel or programming, depending on each organization’s needs.
Organizations applying for the grant are required to submit a proposal outlining what activities the Fellowship program will support and the potential impact of the additional funding. Recipients are responsible for providing an outcomes report to Cytokinetics to measure impact at the end of the funding period.
Organizations must have nonprofit status in the United States.
Organizations must serve patient communities in ALS, heart failure, HCM or SMA.
National organizations and local chapters are encouraged to apply.
After you submit your application, you will receive confirmation via email that your application has been received. If you do not receive a confirmation email, please contact Diane Weiser at email@example.com.
All qualifying applications will be reviewed by a cross-functional team at Cytokinetics comprised of several members with expertise in patient advocacy. Each application will be reviewed based on predetermined criteria including need for additional support in communications and outreach and proposed activities described in the application.
Each organization will be contacted via email to notify them of their acceptance. We will publicly announce this year’s recipients of the Communications Fellowship in January 2021.